Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trafficking protein particle complex subunit 12 (TRAPPC12) is an essential subunit of the TRAPPIII complex, which modulates COPII vesicle assembly at endoplasmic reticulum (ER) exit sites to ensure efficient transport from the ER to the Golgi. It is also enriched in the ER–Golgi intermediate compartment. Beyond its central role in vesicle trafficking, TRAPPC12 directly participates in chromosome congression, kinetochore assembly, and recruitment of CENP-E during mitosis. Mutations in TRAPPC12 disrupt Golgi organization, delay ER-to-Golgi protein trafficking, and cause defects in mitotic progression, as well as ciliogenesis, contributing to the development of severe childhood encephalopathy with a constellation of neurodevelopmental deficits. TRAPPC12 is not a classic drug target such as a receptor, enzyme, or transporter, and there are currently no known drugs or targeted mechanisms of action. It is primarily studied for its fundamental roles in cellular trafficking and human neurodevelopmental disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trafficking protein particle complex subunit 12 (TRAPPC12).